喹唑啉酮类希夫碱及其Cu(II)配合物的抗菌和抗生物膜活性

Š. Pospíšilová, Jana Hricovíniová, A. Čížek, Z. Hricovíniová, J. Jampílek
{"title":"喹唑啉酮类希夫碱及其Cu(II)配合物的抗菌和抗生物膜活性","authors":"Š. Pospíšilová, Jana Hricovíniová, A. Čížek, Z. Hricovíniová, J. Jampílek","doi":"10.3390/ecmc2019-06299","DOIUrl":null,"url":null,"abstract":"According to the last WHO report, the level of bacterial resistance is alarming all over the world. Drug resistant diseases cause at least 700 000 deaths a year [1]. The synthesis of new antibacterial compounds is an important step to overcome this problem.\nShiff bases are a privileged structure possessing a wide spectrum of pharmacological activities such as anticancer, antioxidant and antibacterial [2]. The synthesis of 3‑[(2‑hydroxy‑5‑nitrobenzylidene)amino]‑2‑(2‑hydroxy‑5‑nitrophenyl)‑2,3‑dihydroquinazolin‑4(1H)‑one was described, and its spectral analysis, antioxidant and cytotoxic activities were presented [3]. The aim of this work was to study the antibacterial activity of this compound and its Cu(II) complex [4] against a spectrum of bacterial strains as well as the eradication activity against S. aureus biofilm.\nThe compounds showed moderate antibacterial activity, which was slightly higher in the case of Cu(II) complex. The dynamics of activity against S. aureus was analyzed using the time-kill curve method, and the activity was considered as bacteriostatic. Minimum biofilm eradication activity (MBEC90) against staphylococcal biofilm was only twofold higher than MIC against planktonic cells, which shows a great potential of these derivatives as anti-biofilm active drugs.\n \nThis study was supported by the Ministry of Education of the Czech Republic (LO1305) and by project VEGA 2/0022/18.\n \nReferences:\n\nNo time to wait–securing the future from drug-resistant infections. Report to the Secretary General of the Nations, 2019, https://www.who.int/docs/default-source/documents/no-time-to-wait-securing-the-future-from-drug-resistant-infections-en.pdf?sfvrsn=5b424d7_6.\n Sztanke, K.; Maziarka, A.; Osinka, A.; Sztanke, M. An insight into synthetic Schiff bases revealing antiproliferative activities in vitro. Med. Chem. 2013, 21(13):2648–3666.\nHricoviniova, Z. Hricovini, M.; Kozics, K. New series of quinazolinone derived Schiff’s bases: synthesis, spectroscopic properties and evaluation of their antioxidant and cytotoxic activity. Pap. 2018, 72(4): 1041–1053.\nHricoviniova, Z. et al. manuscript in preparation","PeriodicalId":312909,"journal":{"name":"Proceedings of 5th International Electronic Conference on Medicinal Chemistry","volume":"80 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2019-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Antibacterial and anti-biofilm activity of quinazolinone derived Schiff base and its Cu(II) complex\",\"authors\":\"Š. Pospíšilová, Jana Hricovíniová, A. Čížek, Z. Hricovíniová, J. Jampílek\",\"doi\":\"10.3390/ecmc2019-06299\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"According to the last WHO report, the level of bacterial resistance is alarming all over the world. Drug resistant diseases cause at least 700 000 deaths a year [1]. The synthesis of new antibacterial compounds is an important step to overcome this problem.\\nShiff bases are a privileged structure possessing a wide spectrum of pharmacological activities such as anticancer, antioxidant and antibacterial [2]. The synthesis of 3‑[(2‑hydroxy‑5‑nitrobenzylidene)amino]‑2‑(2‑hydroxy‑5‑nitrophenyl)‑2,3‑dihydroquinazolin‑4(1H)‑one was described, and its spectral analysis, antioxidant and cytotoxic activities were presented [3]. The aim of this work was to study the antibacterial activity of this compound and its Cu(II) complex [4] against a spectrum of bacterial strains as well as the eradication activity against S. aureus biofilm.\\nThe compounds showed moderate antibacterial activity, which was slightly higher in the case of Cu(II) complex. The dynamics of activity against S. aureus was analyzed using the time-kill curve method, and the activity was considered as bacteriostatic. Minimum biofilm eradication activity (MBEC90) against staphylococcal biofilm was only twofold higher than MIC against planktonic cells, which shows a great potential of these derivatives as anti-biofilm active drugs.\\n \\nThis study was supported by the Ministry of Education of the Czech Republic (LO1305) and by project VEGA 2/0022/18.\\n \\nReferences:\\n\\nNo time to wait–securing the future from drug-resistant infections. Report to the Secretary General of the Nations, 2019, https://www.who.int/docs/default-source/documents/no-time-to-wait-securing-the-future-from-drug-resistant-infections-en.pdf?sfvrsn=5b424d7_6.\\n Sztanke, K.; Maziarka, A.; Osinka, A.; Sztanke, M. An insight into synthetic Schiff bases revealing antiproliferative activities in vitro. Med. Chem. 2013, 21(13):2648–3666.\\nHricoviniova, Z. Hricovini, M.; Kozics, K. New series of quinazolinone derived Schiff’s bases: synthesis, spectroscopic properties and evaluation of their antioxidant and cytotoxic activity. Pap. 2018, 72(4): 1041–1053.\\nHricoviniova, Z. et al. manuscript in preparation\",\"PeriodicalId\":312909,\"journal\":{\"name\":\"Proceedings of 5th International Electronic Conference on Medicinal Chemistry\",\"volume\":\"80 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2019-10-30\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Proceedings of 5th International Electronic Conference on Medicinal Chemistry\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.3390/ecmc2019-06299\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Proceedings of 5th International Electronic Conference on Medicinal Chemistry","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3390/ecmc2019-06299","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

根据世界卫生组织的最新报告,世界各地的细菌耐药性水平令人震惊。耐药疾病每年至少造成70万人死亡。新型抗菌化合物的合成是克服这一难题的重要一步。shift碱基是一种特殊的结构,具有广泛的药理活性,如抗癌、抗氧化和抗菌等。报道了3 -[(2 -羟基- 5 -硝基苄基)氨基]- 2 -(2 -羟基- 5 -硝基苯基)- 2,3 -二氢喹唑啉- 4(1H) - one的合成,并对其进行了光谱分析、抗氧化和细胞毒活性测定。本研究旨在研究该化合物及其Cu(II)配合物[4]对多种细菌的抑菌活性以及对金黄色葡萄球菌生物膜的根除活性。该化合物具有中等抑菌活性,其中Cu(II)配合物抑菌活性稍高。采用时间杀伤曲线法分析了其对金黄色葡萄球菌的活性动态,认为其具有抑菌作用。对葡萄球菌生物膜的最小生物膜根除活性(MBEC90)仅比对浮游细胞的MIC高2倍,显示了这些衍生物作为抗生物膜活性药物的巨大潜力。本研究得到了捷克共和国教育部(LO1305)和VEGA 2/0022/18项目的支持。参考文献:没有时间等待-确保未来免受耐药感染。提交联合国秘书长的报告,2019年,https://www.who.int/docs/default-source/documents/no-time-to-wait-securing-the-future-from-drug-resistant-infections-en.pdf?sfvrsn=5b424d7_6。Sztanke k;Maziarka, a;Osinka, a;在体外揭示抗增殖活性的合成希夫碱基的见解。医学化学,2013,21(13):2648-3666。Hricoviniova, Z. Hricovini, M.;新系列喹唑啉酮衍生的希夫碱:合成、光谱性质及其抗氧化和细胞毒活性的评价。植物学报,2018,72(4):1041-1053。Hricoviniova, Z.等人的手稿正在准备中
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Antibacterial and anti-biofilm activity of quinazolinone derived Schiff base and its Cu(II) complex
According to the last WHO report, the level of bacterial resistance is alarming all over the world. Drug resistant diseases cause at least 700 000 deaths a year [1]. The synthesis of new antibacterial compounds is an important step to overcome this problem. Shiff bases are a privileged structure possessing a wide spectrum of pharmacological activities such as anticancer, antioxidant and antibacterial [2]. The synthesis of 3‑[(2‑hydroxy‑5‑nitrobenzylidene)amino]‑2‑(2‑hydroxy‑5‑nitrophenyl)‑2,3‑dihydroquinazolin‑4(1H)‑one was described, and its spectral analysis, antioxidant and cytotoxic activities were presented [3]. The aim of this work was to study the antibacterial activity of this compound and its Cu(II) complex [4] against a spectrum of bacterial strains as well as the eradication activity against S. aureus biofilm. The compounds showed moderate antibacterial activity, which was slightly higher in the case of Cu(II) complex. The dynamics of activity against S. aureus was analyzed using the time-kill curve method, and the activity was considered as bacteriostatic. Minimum biofilm eradication activity (MBEC90) against staphylococcal biofilm was only twofold higher than MIC against planktonic cells, which shows a great potential of these derivatives as anti-biofilm active drugs. This study was supported by the Ministry of Education of the Czech Republic (LO1305) and by project VEGA 2/0022/18. References: No time to wait–securing the future from drug-resistant infections. Report to the Secretary General of the Nations, 2019, https://www.who.int/docs/default-source/documents/no-time-to-wait-securing-the-future-from-drug-resistant-infections-en.pdf?sfvrsn=5b424d7_6. Sztanke, K.; Maziarka, A.; Osinka, A.; Sztanke, M. An insight into synthetic Schiff bases revealing antiproliferative activities in vitro. Med. Chem. 2013, 21(13):2648–3666. Hricoviniova, Z. Hricovini, M.; Kozics, K. New series of quinazolinone derived Schiff’s bases: synthesis, spectroscopic properties and evaluation of their antioxidant and cytotoxic activity. Pap. 2018, 72(4): 1041–1053. Hricoviniova, Z. et al. manuscript in preparation
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信